Skip to main content
PMC home page
Biophysical Journal logoLink to Biophysical Journal
. 1999 Mar;76(3):1679–1692. doi: 10.1016/S0006-3495(99)77327-3

T-cell stimulation through the T-cell receptor/CD3 complex regulates CD2 lateral mobility by a calcium/calmodulin-dependent mechanism.

S Q Liu 1, D E Golan 1
PMCID: PMC1300144  PMID: 10049348

Abstract

T lymphocyte activation through the T cell receptor (TCR)/CD3 complex alters the avidity of the cell surface adhesion receptor CD2 for its ligand CD58. Based on the observations that activation-associated increases in intracellular [Ca2+] ([Ca2+]i) strengthen interactions between T cells and antigen-presenting cells, and that the lateral mobility of cell surface adhesion receptors is an important regulator of cellular adhesion strength, we postulated that [Ca2+]i controls CD2 lateral mobility at the T cell surface. Human Jurkat T leukemia cells were stimulated by antibody-mediated cross-linking of the TCR/CD3 complex. CD2 was labeled with a fluorescently conjugated monoclonal antibody. Quantitative fluorescence microscopy techniques were used to measure [Ca2+]i and CD2 lateral mobility. Cross-linking of the TCR/CD3 complex caused an immediate increase in [Ca2+]i and, 10-20 min later, a decrease in the fractional mobility of CD2 from the control value of 68 +/- 1% to 45 +/- 2% (mean +/- SEM). One to two hours after cell stimulation the fractional mobility spontaneously returned to the control level. Under these and other treatment conditions, the fraction of cells with significantly elevated [Ca2+]i was highly correlated with the fraction of cells manifesting significantly reduced CD2 mobility. Pretreatment of cells with a calmodulin inhibitor or a calmodulin-dependent kinase inhibitor prevented Ca2+-mediated CD2 immobilization, and pretreatment of cells with a calcineurin phosphatase inhibitor prevented the spontaneous reversal of CD2 immobilization. These data suggest that T cell activation through the TCR/CD3 complex controls CD2 lateral mobility by a Ca2+/calmodulin-dependent mechanism, and that this mechanism may involve regulated phosphorylation and dephosphorylation of CD2 or a closely associated protein.

Full Text

The Full Text of this article is available as a PDF (146.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander D., Goris J., Marais R., Rothbard J., Merlevede W., Crumpton M. J. Dephosphorylation of the human T lymphocyte CD3 antigen. Eur J Biochem. 1989 Apr 15;181(1):55–65. doi: 10.1111/j.1432-1033.1989.tb14693.x. [DOI] [PubMed] [Google Scholar]
  2. Arulanandam A. R., Moingeon P., Concino M. F., Recny M. A., Kato K., Yagita H., Koyasu S., Reinherz E. L. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice. J Exp Med. 1993 May 1;177(5):1439–1450. doi: 10.1084/jem.177.5.1439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Axelrod D., Koppel D. E., Schlessinger J., Elson E., Webb W. W. Mobility measurement by analysis of fluorescence photobleaching recovery kinetics. Biophys J. 1976 Sep;16(9):1055–1069. doi: 10.1016/S0006-3495(76)85755-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bernard A., Knowles R. W., Naito K., Dupont B., Raynal B., Tran H. C., Boumsell L. A unique epitope on the CD2 molecule defined by the monoclonal antibody 9-1: epitope-specific modulation of the E-rosette receptor and effects on T-cell functions. Hum Immunol. 1986 Dec;17(4):388–405. doi: 10.1016/0198-8859(86)90299-5. [DOI] [PubMed] [Google Scholar]
  5. Bierer B. E., Golan D. E., Brown C. S., Herrmann S. H., Burakoff S. J. A monoclonal antibody to LFA-3, the CD2 ligand, specifically immobilizes major histocompatibility complex proteins. Eur J Immunol. 1989 Apr;19(4):661–665. doi: 10.1002/eji.1830190414. [DOI] [PubMed] [Google Scholar]
  6. Bierer B. E., Holländer G., Fruman D., Burakoff S. J. Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Curr Opin Immunol. 1993 Oct;5(5):763–773. doi: 10.1016/0952-7915(93)90135-f. [DOI] [PubMed] [Google Scholar]
  7. Bierer B. E., Schreiber S. L., Burakoff S. J. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation. Eur J Immunol. 1991 Feb;21(2):439–445. doi: 10.1002/eji.1830210228. [DOI] [PubMed] [Google Scholar]
  8. Bland M. M., McDonald O. B., Carrera A. C. p56lck phosphorylation by Ca2+/calmodulin-dependent protein kinase type II. Biochem Biophys Res Commun. 1994 Jan 14;198(1):67–73. doi: 10.1006/bbrc.1994.1010. [DOI] [PubMed] [Google Scholar]
  9. Boniface J. J., Davis M. M. T-cell recognition of antigen. A process controlled by transient intermolecular interactions. Ann N Y Acad Sci. 1995 Sep 7;766:62–69. doi: 10.1111/j.1749-6632.1995.tb26649.x. [DOI] [PubMed] [Google Scholar]
  10. Chan P. Y., Lawrence M. B., Dustin M. L., Ferguson L. M., Golan D. E., Springer T. A. Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2. J Cell Biol. 1991 Oct;115(1):245–255. doi: 10.1083/jcb.115.1.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Clipstone N. A., Crabtree G. R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 1992 Jun 25;357(6380):695–697. doi: 10.1038/357695a0. [DOI] [PubMed] [Google Scholar]
  12. Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem. 1989;58:453–508. doi: 10.1146/annurev.bi.58.070189.002321. [DOI] [PubMed] [Google Scholar]
  13. Davis F. B., Davis P. J., Blas S. D. Role of calmodulin in thyroid hormone stimulation in vitro of human erythrocyte Ca2+-ATPase activity. J Clin Invest. 1983 Mar;71(3):579–586. doi: 10.1172/JCI110803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Deckert M., Kubar J., Zoccola D., Bernard-Pomier G., Angelisova P., Horejsi V., Bernard A. CD59 molecule: a second ligand for CD2 in T cell adhesion. Eur J Immunol. 1992 Nov;22(11):2943–2947. doi: 10.1002/eji.1830221128. [DOI] [PubMed] [Google Scholar]
  15. Donnadieu E., Bismuth G., Trautmann A. Antigen recognition by helper T cells elicits a sequence of distinct changes of their shape and intracellular calcium. Curr Biol. 1994 Jul 1;4(7):584–595. doi: 10.1016/s0960-9822(00)00130-5. [DOI] [PubMed] [Google Scholar]
  16. Dustin M. L., Ferguson L. M., Chan P. Y., Springer T. A., Golan D. E. Visualization of CD2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area. J Cell Biol. 1996 Feb;132(3):465–474. doi: 10.1083/jcb.132.3.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Dustin M. L., Springer T. A. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature. 1989 Oct 19;341(6243):619–624. doi: 10.1038/341619a0. [DOI] [PubMed] [Google Scholar]
  18. Dutz J. P., Fruman D. A., Burakoff S. J., Bierer B. E. A role for calcineurin in degranulation of murine cytotoxic T lymphocytes. J Immunol. 1993 Apr 1;150(7):2591–2598. [PubMed] [Google Scholar]
  19. Elliott J. F., Lin Y., Mizel S. B., Bleackley R. C., Harnish D. G., Paetkau V. Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science. 1984 Dec 21;226(4681):1439–1441. doi: 10.1126/science.6334364. [DOI] [PubMed] [Google Scholar]
  20. Emmel E. A., Verweij C. L., Durand D. B., Higgins K. M., Lacy E., Crabtree G. R. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science. 1989 Dec 22;246(4937):1617–1620. doi: 10.1126/science.2595372. [DOI] [PubMed] [Google Scholar]
  21. Flanagan W. M., Corthésy B., Bram R. J., Crabtree G. R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature. 1991 Aug 29;352(6338):803–807. doi: 10.1038/352803a0. [DOI] [PubMed] [Google Scholar]
  22. Fruman D. A., Klee C. B., Bierer B. E., Burakoff S. J. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3686–3690. doi: 10.1073/pnas.89.9.3686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Goding J. W. Conjugation of antibodies with fluorochromes: modifications to the standard methods. J Immunol Methods. 1976;13(3-4):215–226. doi: 10.1016/0022-1759(76)90068-5. [DOI] [PubMed] [Google Scholar]
  24. Golan D. E., Brown C. S., Cianci C. M., Furlong S. T., Caulfield J. P. Schistosomula of Schistosoma mansoni use lysophosphatidylcholine to lyse adherent human red blood cells and immobilize red cell membrane components. J Cell Biol. 1986 Sep;103(3):819–828. doi: 10.1083/jcb.103.3.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Granelli-Piperno A., Andrus L., Steinman R. M. Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J Exp Med. 1986 Apr 1;163(4):922–937. doi: 10.1084/jem.163.4.922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hahn W. C., Burakoff S. J., Bierer B. E. Signal transduction pathways involved in T cell receptor-induced regulation of CD2 avidity for CD58. J Immunol. 1993 Apr 1;150(7):2607–2619. [PubMed] [Google Scholar]
  27. Hahn W. C., Menu E., Bothwell A. L., Sims P. J., Bierer B. E. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science. 1992 Jun 26;256(5065):1805–1807. doi: 10.1126/science.1377404. [DOI] [PubMed] [Google Scholar]
  28. Hanson P. I., Schulman H. Neuronal Ca2+/calmodulin-dependent protein kinases. Annu Rev Biochem. 1992;61:559–601. doi: 10.1146/annurev.bi.61.070192.003015. [DOI] [PubMed] [Google Scholar]
  29. Hashimoto Y., Soderling T. R. Regulation of calcineurin by phosphorylation. Identification of the regulatory site phosphorylated by Ca2+/calmodulin-dependent protein kinase II and protein kinase C. J Biol Chem. 1989 Oct 5;264(28):16524–16529. [PubMed] [Google Scholar]
  30. Hendey B., Klee C. B., Maxfield F. R. Inhibition of neutrophil chemokinesis on vitronectin by inhibitors of calcineurin. Science. 1992 Oct 9;258(5080):296–299. doi: 10.1126/science.1384129. [DOI] [PubMed] [Google Scholar]
  31. Hubbard M. J., Klee C. B. Functional domain structure of calcineurin A: mapping by limited proteolysis. Biochemistry. 1989 Feb 21;28(4):1868–1874. doi: 10.1021/bi00430a066. [DOI] [PubMed] [Google Scholar]
  32. Ingebritsen T. S., Cohen P. Protein phosphatases: properties and role in cellular regulation. Science. 1983 Jul 22;221(4608):331–338. doi: 10.1126/science.6306765. [DOI] [PubMed] [Google Scholar]
  33. Ishikawa N., Hashiba Y., Hidaka H. Effect of a new Ca2(+)-calmodulin-dependent protein kinase II inhibitor on GABA release in cerebrospinal fluid of the rat. J Pharmacol Exp Ther. 1990 Aug;254(2):598–602. [PubMed] [Google Scholar]
  34. Johansson B., Wymann M. P., Holmgren-Peterson K., Magnusson K. E. N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist. J Cell Biol. 1993 Jun;121(6):1281–1289. doi: 10.1083/jcb.121.6.1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kao J. P., Harootunian A. T., Tsien R. Y. Photochemically generated cytosolic calcium pulses and their detection by fluo-3. J Biol Chem. 1989 May 15;264(14):8179–8184. [PubMed] [Google Scholar]
  36. Kato K., Koyanagi M., Okada H., Takanashi T., Wong Y. W., Williams A. F., Okumura K., Yagita H. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med. 1992 Nov 1;176(5):1241–1249. doi: 10.1084/jem.176.5.1241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kino T., Hatanaka H., Hashimoto M., Nishiyama M., Goto T., Okuhara M., Kohsaka M., Aoki H., Imanaka H. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 1987 Sep;40(9):1249–1255. doi: 10.7164/antibiotics.40.1249. [DOI] [PubMed] [Google Scholar]
  38. Kino T., Hatanaka H., Miyata S., Inamura N., Nishiyama M., Yajima T., Goto T., Okuhara M., Kohsaka M., Aoki H. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 1987 Sep;40(9):1256–1265. doi: 10.7164/antibiotics.40.1256. [DOI] [PubMed] [Google Scholar]
  39. Klee C. B. Concerted regulation of protein phosphorylation and dephosphorylation by calmodulin. Neurochem Res. 1991 Sep;16(9):1059–1065. doi: 10.1007/BF00965851. [DOI] [PubMed] [Google Scholar]
  40. Klee C. B., Draetta G. F., Hubbard M. J. Calcineurin. Adv Enzymol Relat Areas Mol Biol. 1988;61:149–200. doi: 10.1002/9780470123072.ch4. [DOI] [PubMed] [Google Scholar]
  41. Koyasu S., Lawton T., Novick D., Recny M. A., Siliciano R. F., Wallner B. P., Reinherz E. L. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2603–2607. doi: 10.1073/pnas.87.7.2603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Krönke M., Leonard W. J., Depper J. M., Arya S. K., Wong-Staal F., Gallo R. C., Waldmann T. A., Greene W. C. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A. 1984 Aug;81(16):5214–5218. doi: 10.1073/pnas.81.16.5214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Lawson M. A., Maxfield F. R. Ca(2+)- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature. 1995 Sep 7;377(6544):75–79. doi: 10.1038/377075a0. [DOI] [PubMed] [Google Scholar]
  44. Lee T. P., Venuti J., Macara I., Kawauchi R., Davis P. J., Mookerjee B. K. Characteristics of calmodulin binding to purified human lymphocyte plasma membranes. J Immunol. 1987 Jul 1;139(1):42–48. [PubMed] [Google Scholar]
  45. Liu J., Albers M. W., Wandless T. J., Luan S., Alberg D. G., Belshaw P. J., Cohen P., MacKintosh C., Klee C. B., Schreiber S. L. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry. 1992 Apr 28;31(16):3896–3901. doi: 10.1021/bi00131a002. [DOI] [PubMed] [Google Scholar]
  46. Liu J., Farmer J. D., Jr, Lane W. S., Friedman J., Weissman I., Schreiber S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991 Aug 23;66(4):807–815. doi: 10.1016/0092-8674(91)90124-h. [DOI] [PubMed] [Google Scholar]
  47. Liu S. J., Hahn W. C., Bierer B. E., Golan D. E. Intracellular mediators regulate CD2 lateral diffusion and cytoplasmic Ca2+ mobilization upon CD2-mediated T cell activation. Biophys J. 1995 Feb;68(2):459–470. doi: 10.1016/S0006-3495(95)80207-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Martz E., Heagy W., Gromkowski S. H. The mechanism of CTL-mediated killing: monoclonal antibody analysis of the roles of killer and target-cell membrane proteins. Immunol Rev. 1983;72:73–96. doi: 10.1111/j.1600-065x.1983.tb01073.x. [DOI] [PubMed] [Google Scholar]
  49. Martz E. Mechanism of specific tumor-cell lysis by alloimmune T lymphocytes: resolution and characterization of discrete steps in the cellular interaction. Contemp Top Immunobiol. 1977;7:301–361. doi: 10.1007/978-1-4684-3054-7_9. [DOI] [PubMed] [Google Scholar]
  50. Negulescu P. A., Krasieva T. B., Khan A., Kerschbaum H. H., Cahalan M. D. Polarity of T cell shape, motility, and sensitivity to antigen. Immunity. 1996 May;4(5):421–430. doi: 10.1016/s1074-7613(00)80409-4. [DOI] [PubMed] [Google Scholar]
  51. Nghiem P., Saati S. M., Martens C. L., Gardner P., Schulman H. Cloning and analysis of two new isoforms of multifunctional Ca2+/calmodulin-dependent protein kinase. Expression in multiple human tissues. J Biol Chem. 1993 Mar 15;268(8):5471–5479. [PubMed] [Google Scholar]
  52. Poenie M., Tsien R. Y., Schmitt-Verhulst A. M. Sequential activation and lethal hit measured by [Ca2+]i in individual cytolytic T cells and targets. EMBO J. 1987 Aug;6(8):2223–2232. doi: 10.1002/j.1460-2075.1987.tb02494.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Premack B. A., Gardner P. Signal transduction by T-cell receptors: mobilization of Ca and regulation of Ca-dependent effector molecules. Am J Physiol. 1992 Dec;263(6 Pt 1):C1119–C1140. doi: 10.1152/ajpcell.1992.263.6.C1119. [DOI] [PubMed] [Google Scholar]
  54. Sanchez-Madrid F., Krensky A. M., Ware C. F., Robbins E., Strominger J. L., Burakoff S. J., Springer T. A. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7489–7493. doi: 10.1073/pnas.79.23.7489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Schreiber S. L. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 1991 Jan 18;251(4991):283–287. doi: 10.1126/science.1702904. [DOI] [PubMed] [Google Scholar]
  56. Schreiber S. L., Crabtree G. R. The mechanism of action of cyclosporin A and FK506. Immunol Today. 1992 Apr;13(4):136–142. doi: 10.1016/0167-5699(92)90111-J. [DOI] [PubMed] [Google Scholar]
  57. Schulman H., Hanson P. I., Meyer T. Decoding calcium signals by multifunctional CaM kinase. Cell Calcium. 1992 Jun-Jul;13(6-7):401–411. doi: 10.1016/0143-4160(92)90053-u. [DOI] [PubMed] [Google Scholar]
  58. Schulman H. The multifunctional Ca2+/calmodulin-dependent protein kinases. Curr Opin Cell Biol. 1993 Apr;5(2):247–253. doi: 10.1016/0955-0674(93)90111-3. [DOI] [PubMed] [Google Scholar]
  59. Shaw A. S., Dustin M. L. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity. 1997 Apr;6(4):361–369. doi: 10.1016/s1074-7613(00)80279-4. [DOI] [PubMed] [Google Scholar]
  60. Springer T. A. Adhesion receptors of the immune system. Nature. 1990 Aug 2;346(6283):425–434. doi: 10.1038/346425a0. [DOI] [PubMed] [Google Scholar]
  61. Stolpen A. H., Golan D. E., Pober J. S. Tumor necrosis factor and immune interferon act in concert to slow the lateral diffusion of proteins and lipids in human endothelial cell membranes. J Cell Biol. 1988 Aug;107(2):781–789. doi: 10.1083/jcb.107.2.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Thatte H. S., Bridges K. R., Golan D. E. Microtubule inhibitors differentially affect translational movement, cell surface expression, and endocytosis of transferrin receptors in K562 cells. J Cell Physiol. 1994 Aug;160(2):345–357. doi: 10.1002/jcp.1041600216. [DOI] [PubMed] [Google Scholar]
  63. Thomson A. W. FK-506--how much potential? Immunol Today. 1989 Jan;10(1):6–9. doi: 10.1016/0167-5699(89)90057-1. [DOI] [PubMed] [Google Scholar]
  64. Tocci M. J., Matkovich D. A., Collier K. A., Kwok P., Dumont F., Lin S., Degudicibus S., Siekierka J. J., Chin J., Hutchinson N. I. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol. 1989 Jul 15;143(2):718–726. [PubMed] [Google Scholar]
  65. Tokumitsu H., Chijiwa T., Hagiwara M., Mizutani A., Terasawa M., Hidaka H. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II. J Biol Chem. 1990 Mar 15;265(8):4315–4320. [PubMed] [Google Scholar]
  66. Valverde I., Sener A., Lebrun P., Herchuelz A., Malaisse W. J. The stimulus-secretion coupling of glucose-induced insulin release. XLVII. The possible role of calmodulin. Endocrinology. 1981 Apr;108(4):1305–1312. doi: 10.1210/endo-108-4-1305. [DOI] [PubMed] [Google Scholar]
  67. Weiss A., Littman D. R. Signal transduction by lymphocyte antigen receptors. Cell. 1994 Jan 28;76(2):263–274. doi: 10.1016/0092-8674(94)90334-4. [DOI] [PubMed] [Google Scholar]
  68. Wülfing C., Rabinowitz J. D., Beeson C., Sjaastad M. D., McConnell H. M., Davis M. M. Kinetics and extent of T cell activation as measured with the calcium signal. J Exp Med. 1997 May 19;185(10):1815–1825. doi: 10.1084/jem.185.10.1815. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES